Whilst there are no official diagnostic criteria for VEXAS syndrome, VEXAS is characterized by the co-existence of acquired inflammatory and hematological symptoms as well as the presence of vacuoles in hematopoietic stem and progenitor cells and somatic UBA1 mutations [4, 24]. This evidence concerns the gene UBA1 and VEXAS syndrome.